Fig. 1From: Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults recently diagnosed with schizophreniaStudy population flowchart for Medicaid patients with schizophrenia initiated on PP1M or OAA. PP1M = once-monthly paliperidone palmitate; OAA = oral atypical antipsychotics. Data source: Medicaid database: Iowa, Kansas, Mississippi, Missouri, and New Jersey. 1OAA agents include aripiprazole, asenapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, and ziprasidone. 2Initiation of an antipsychotic agent is defined as having ≥2 claims for the same agent within 90 days and no claim of the same agent during the 12 months before the first claimBack to article page